facebook twitter linkedin
  • images/stories/slider.png
  • images/stories/slider2.png
  • images/stories/slider3.png
  • images/stories/slider4.png

NEWS RELEASES

  • Selvita files IND Application for its novel, dual PIM/FLT3 inhibitor in AML

    Kraków, Poland - April 18, 2016 - Selvita (WSE:SLV), the largest drug discovery company in Central and Eastern Europe, has submitted an investigational new drug (IND) application to the U.S. Food and Drug Administration (FDA) for SEL24, the first com…

    Read More...

  • Selvita enjoys strong growth in 2015

    Krakow, Poland - March 23, 2016 – Selvita, the largest drug discovery company in Central and Eastern Europe, has reported another year of a double digit revenue growth. &n In 2015, the company has enjoyed strong growth of revenues, which amounted to…

    Read More...

  • Selvita Bridges Krakow and San Francisco

    San Bruno, CA – March 11, 2016 - Selvita, the largest drug discovery company in Central and Eastern Europe, has just opened its West Coast US office, located in San Bruno, CA. Selvita has initiated its US operations in September 2015, opening a full…

    Read More...